Skincare brand Be Clinical raises Rs 6 Cr in seed funding round

Be Clinical, an evidence-led skincare brand focused on clinically effective solutions for ageing skin, has raised Rs 6 crore in seed funding. The round was led by V3 Ventures, with participation from Titan Capital, founded by Kunal Bahl and Rohit Bansal, who have doubled down on their commitment to the brand.

Founded by Hemangi Dhir, Be Clinical was created to address a clear gap in the Indian skincare market — the lack of science-led, transparent, and clinically validated solutions designed specifically for Indian skin and environmental conditions. While much of the category is driven by marketing claims or inaccessible clinical treatments, Be Clinical differentiates itself through in-vivo tested, clinically validated formulations, supported by end-to-end in-house research and manufacturing and responsible formulation.

The seed capital will be strategically deployed across three core areas. A significant portion will be invested in research and development to strengthen in-house formulation capabilities, conduct clinical testing, and develop targeted solutions for ageing concerns across the face, body, and scalp. The company will also expand its manufacturing facility by adding advanced machinery to improve production capacity, consistency, and quality control.

In addition, part of the funding will be used to upgrade packaging with functional, protective, and premium formats that preserve ingredient efficacy while reinforcing the brand’s clinical-grade positioning.